Icon

ZYRTEC ALLERGY (nda019835)- (5MG,10MG)

CETIRIZINE HYDROCHLORIDE J AND J CONSUMER INC
5MG,10MG
No No
Expired Expired
None None
None No
ZYRTEC ALLERGY Tablets are indicated for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older.
28 0 11
Total Other Developers 5
Drugs with Suitability No
5MG ** ** - - 3
10MG ** ** - - 8
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ****** ****** ** ****** *************** ** *** ****, *** *********** ** ***** ***, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** *** *&* **************, ***. *********** *** ******** ****., *********, *** **** (**) *****, ****** ****** (***) ***
****** ****** ****** ****** *************** ******* ******* *********** **** **.** (****) *** ** (****), ****** ********** ****, ***************, *************, ***********, ***** **** ******, ***** (***) ***
****** ******** ****** ******** ****** ******* *********** **** ** *-** & *-**, ***** ********** ******,, *****, *** ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ******** ******** ***** ******* *********** **.**. ***/*, ***/*, ***, ***/*, ********** *******, ********-************* ******, *******-********** ********, ********* ******, ***** (***) ***
****** ****** ****** ******** ******* *********** *** *****-*, *-**, ***** ********** ****, *****, ***, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.